Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles

Thrombosis Research

Volumn 136, Issue 1, 2015, Pages 161-163

  Pengo, V ^a   Ruffatti, A ^a   Tonello, M ^a   Hoxha, A ^a   Bison, E ^a   Denas, G ^a   Padayattil Jose, S ^a   Zoppellaro, G ^a   Bracco, A ^a   Banzato, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antibodies; Antiphospholipid syndrome; Epitopes; Glycoproteins; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; BETA2 GLYCOPROTEIN 1; EPITOPE;

ANTIBODY DETECTION; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; OPTICAL DENSITY; PRIORITY JOURNAL; THROMBOEMBOLISM; ANTIPHOSPHOLIPID SYNDROME; BLOOD; CHEMISTRY; IMMUNOLOGY; PROTEIN TERTIARY STRUCTURE;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CROSS-SECTIONAL STUDIES; EPITOPES; HUMANS; IMMUNOGLOBULIN G; PROTEIN STRUCTURE, TERTIARY;

EID: 84931566678     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.04.031     Document Type: Article

References (18)

1. S. Miyakis, M.D. Lockshin, T. Atsumi, D.W. Branch, R.L. Brey, and R. Cervera International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 2006 295 306
2. V. Pengo, A. Ruffatti, C. Legnani, P. Gresele, D. Barcellona, and N. Erba Clinical course of high-risk patients diagnosed with antiphospholipid syndrome J Thromb Haemost 8 2010 237 242
3. M. Galli, D. Luciani, G. Bertolini, and T. Barbui Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature Blood 101 2003 1827 1832
4. V. Pengo, A. Biasiolo, P. Rampazzo, and T. Brocco dRVVT is more sensitive than KCT or TTI for detecting Lupus Anticoagulant activity of anti-β2-Glycoprotein-I autoantibodies Thromb Haemost 81 1999 256 258
5. A. Tripodi, P.G. de Groot, and V. Pengo Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment J Intern Med 270 2 2011 110 122
6. B. de Laat, R.H. Derksen, R.T. Urbanus, and P.G. de Groot IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis Blood 105 2005 1540 1545
7. B. de Laat, V. Pengo, I. Pabinger, J. Musial, A.E. Voskuyl, and I.E. Bultink The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study J Thromb Haemost 7 2009 1767 1773
8. S.S. Pierangeli, P.G. de Groot, J. Dlott, R. Favaloro, E.N. Harris, and G. Lakos 'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010 Lupus 20 2011 182 908
9. K.M. Devreese, S.S. Pierangeli, B. de Laat, A. Tripodi, T. Atsumi, and T.L. Ortel Subcommittee on Lupus Anticoagulant/Phospholipid/Dependent Antibodies. Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH J Thromb Haemost 12 5 May 2014 792 795
10. V. Pengo, A. Tripodi, G. Reber, J.H. Rand, T.L. Ortel, and M. Galli Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis J Thromb Haemost 7 2009 1737 1740
11. A. Banzato, N. Pozzi, R. Frasson, V. De Filippis, A. Ruffatti, and E. Bison Antibodies to domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS) Thromb Res 128 2011 583 586
12. V. Pengo, A. Ruffatti, M. Tonello, S. Cuffaro, A. Banzato, and E. Bison Antibodies to Domain 1 (Dm1) of β2-Glycoprotein 1 (β2GP1) correctly classify patients at risk in Antiphospholipid Syndrome (APS) J Thromb Haemost Feb 2 2015 10.1111/jth.12865
13. C. Agostinis, P. Durigutto, D. Sblattero, M.O. Borghi, C. Grossi, and F. Guida A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome Blood 123 2014 3478 3487
14. L. Andreoli, C. Nalli, M. Motta, G.L. Norman, Z. Shums, and S. Encabo Anti-β2glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain4/5: might it be the reason for their innocent' profile? Ann Rheum Dis 70 2011 380 383
15. G.M. Iverson, C.A. von Muhlen, H.L. Staub, A.J. Lassen, W. Binder, and G.L. Norman Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain4 of beta2-GPI J Autoimmun 27 2006 266 271
16. J. Arvieux, Y. Renaudineau, I. Mane, R. Perraut, S.A. Krilis, and P. Youinou Distinguishing features of anti-beta2glycoprotein Iantibodies between patients with leprosy and the antiphospholipid syndrome Thromb Haemost 87 2002 599 605
17. A. Ambrozic, T. Avicin, K. Ichikawa, T. Kveder, E. Matsuura, and M. Hojnik Antibeta(2)-glycoprotein I antibodies in children with atopic dermatitis Int Immunol 14 2002 823 830
18. V. Pengo, A. Ruffatti, T. Del Ross, M. Tonello, S. Cuffaro, and A. Hoxha Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile J Thromb Haemost 11 2013 1 5